VVelarionINTELLIGENCE
Sign inStart free trial
Start free trial

LifeStance Health Group Executive Compensation (FY25)

LFST · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025
◇
David Bourdon
Median of the other named officers
$3,084,857
6 officers, excluding the chief executive
Latest say-on-pay support
=
June 2, 2026
Velarion Intel, $5,000/year: one seat · one year · every company we cover, with dashboards, peer screens and board-ready briefs.
See every company’s exec pay — free for 3 days, no cardSee the plan and pricing
Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.

The paid brief on LifeStance Health Group

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $500 for the board report; $900 for both.
7 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
LifeStance Health Group brief$500Get the executive brief
Velarion Intel, one year, every company
332 figures on this page: 329 cited to the filing that reported them, 3 calculated from figures it prints. See the citations

More on LifeStance Health Group

Five data products on this company. Each one is requested through the developer setup page.
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — David Bourdon: $3,446,530 → $6,645,380 (92.8% higher)
Say-on-pay support: 91.7% → 98.3% (6.6 points higher)

Frequently asked questions

Answers drawn from the data on this page.
Who is LifeStance Health Group's chief executive and what were they paid?
David Bourdon, Chief Executive Officer, received $6,645,380 in total compensation for fiscal 2025. Bourdon's total moved 92.8% higher from the $3,446,530 reported for fiscal 2024.
What was LifeStance Health Group's say-on-pay result?
Shareholders supported the say-on-pay proposal with 98.3% of votes cast for or against in favor at the meeting held June 2, 2026 for fiscal 2025.
Which companies are in LifeStance Health Group's peer group?
The disclosed peer group includes Addus HomeCare Corporation, Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.), Enhabit, Inc., GoodRx Holdings, Inc. and Hims & Hers Health, Inc., among others.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Kenneth Burdick
Chief Executive Officer
◇——◇——◇◇
Danish Qureshi
President and Chief Operating Officer
◇—◇◇——◇◇
Michael Lester
Former President and Chief Executive Officer
Departed during or after this year
◇—◇———◇◇
David Bourdon
Chief Financial Officer and Treasurer
◇—◇◇——◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Kenneth Burdick
Chief Executive Officer
◇—◇—◇—◇◇
Danish Qureshi
President and Chief Operating Officer
◇—◇—◇—◇◇
David Bourdon
Chief Financial Officer and Treasurer
◇—◇—◇—◇◇
Pablo Pantaleoni
Former Chief Digital Officer
◇—◇—◇—◇◇
Ryan Pardo
Chief Legal Officer and Secretary
◇—◇—◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Danish Qureshi
Former President and Chief Operating Officer
Departed during or after this year
◇—◇◇——◇◇
Kenneth Burdick
Executive Chairperson; Former Chief Executive Officer
Departed during or after this year
◇—◇—◇—◇◇
David Bourdon
Chief Executive Officer
◇—◇—◇—◇◇
Pablo Pantaleoni
Chief Digital Officer
◇—◇—◇—◇◇
Ryan Pardo
Chief Legal Officer and Secretary
◇—◇—◇—◇◇
Kevin Mullins
Former Chief Development Officer
Departed during or after this year
◇—◇————◇
Ann Varanakis
Chief People Officer
◇—◇—◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Kenneth Burdick
Executive Chairperson; Former Chief Executive Officer
Departed during or after this year
◇—◇—◇—◇◇
David Bourdon
Chief Executive Officer
◇—◇—◇—◇◇
Ryan McGroarty
Chief Financial Officer and Treasurer
◇◇◇—◇—◇◇
Pablo Pantaleoni
Former Chief Digital Officer
Departed during or after this year
◇—◇———◇◇
Ryan Pardo
Chief Legal Officer and Secretary
◇—◇—◇—◇◇
Ann Varanakis
Chief People Officer
◇—◇—◇—◇◇
Vaughn Paunovich
Chief Technology Officer
◇—◇—◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Ann VaranakisPSU◇◇◇———◇
Ann VaranakisPSU◇◇◇—◇—◇
Ann VaranakisPSU◇◇◇———◇
Ann VaranakisRSU◇——◇——◇
David BourdonPSU◇◇◇———◇
David BourdonRSU◇——◇——◇
David BourdonPSU◇◇◇———◇
David BourdonPSU◇◇◇—◇—◇
Kenneth BurdickPSU◇◇◇———◇
Kenneth BurdickRSU◇——◇——◇
Kenneth BurdickPSU◇◇◇———◇
Kenneth BurdickPSU◇◇◇—◇—◇
Pablo PantaleoniPSU◇◇◇—◇—◇
Pablo PantaleoniRSU◇——◇——◇
Pablo PantaleoniPSU◇◇◇———◇
Pablo PantaleoniPSU◇◇◇———◇
Ryan McGroartyPSU◇◇◇—◇—◇
Ryan McGroartyPSU◇◇◇—◇—◇
Ryan McGroartyRSU◇——◇——◇
Ryan McGroartyRSU◇——◇——◇
Ryan PardoPSU◇◇◇———◇
Ryan PardoPSU◇◇◇—◇—◇
Ryan PardoRSU◇——◇——◇
Ryan PardoPSU◇◇◇———◇
Vaughn PaunovichRSU◇——◇——◇
Vaughn PaunovichPSU◇◇◇—◇—◇
Fiscal 2022, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Kenneth BurdickRSU◇◇——
Option◇—◇9/7/2032
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Ryan McGroartyRSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
David BourdonRSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇11/10/2032
RSU◇◇——
RSU◇◇——
RSU◇◇——
Ryan PardoPSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Vaughn PaunovichRSU◇◇——
RSU◇◇——
Ann VaranakisRSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Pablo PantaleoniRSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Severance and change in control

The terms as written in the agreements.
David Bourdon
Chief Executive Officer
Severance multiple◇
Severance base◇
Clawback◇
Ryan McGroarty
Chief Financial Officer and Treasurer · Employment agreement
Severance multiple◇
Severance base◇

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Eric Palmer
◇◇————◇
Sarah Personette
◇◇————◇
Teresa DeLuca
◇◇————◇
Eric Shuey
◇◇————◇
Robert Bessler
◇◇————◇
David Bourdon, Katherine Wood, Kenneth Burdick, Jeffrey Rhodes and Darren Black served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Board chair premium◇
Audit committee chair◇
Equity is delivered as restricted stock units.

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Addus HomeCare Corporation ADUS
  • Astrana Health, Inc. (f/k/a Apollo Medical Holdings, Inc.) symbol not shown
  • Enhabit, Inc. EHAB
  • GoodRx Holdings, Inc. GDRX
  • Hims & Hers Health, Inc. HIMS
  • InnovAge Holding Corp. INNV
  • Option Care Health, Inc. OPCH
  • Pediatrix Medical Group, Inc. MD
  • Privia Health Group, Inc. PRVA
  • Talkspace, Inc. TALK
  • Teladoc Health, Inc. TDOC

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025June 2, 2026=◇◇◇
2024June 3, 2025=◇◇◇
2023June 3, 2024=◇◇◇

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- David Bourdon (Chief Executive Officer), FY2025 total compensation $6,645,380 (base salary $657,692) [exec_comp, SEC accession 0001193125-26-170798, filed 2026-04-22]

Answered within 24 hours, every figure cited to its SEC filing. This is a one-off report: no refunds.

Tell me when LifeStance Health Group files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact LifeStance Health Group disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where LifeStance Health Group sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $500
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether LifeStance Health Group's disclosed peer group is defensible, who names LifeStance Health Group back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
332 figures on this page: 329 cited to the filing that reported them, 3 calculated from figures it prints.
329 cited to the filing
3 calculated from the filing

Documents cited

  1. 0001193125-26-257606
    Item 5.07 Submission of Matters to a Vote of Security Holders
  2. 0001193125-26-170798
    Director Compensation · Grants of Plan-Based Awards Table · Potential Payments Upon Termination · Summary Compensation Table
  3. 0001193125-25-136309
    Item 5.07 Submission of Matters to a Vote of Security Holders
  4. 0000950170-25-057496
    Summary Compensation Table
  5. 0001193125-24-154291
    Item 5.07 Submission of Matters to a Vote of Security Holders
  6. 0000950170-24-046929
    Summary Compensation Table
  7. 0000950170-23-013853
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “LifeStance Health Group executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/LFST (accessed 2026).
Short form: data: Velarion

The paid brief for LifeStance Health Group

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $500 for the board report; $900 for both.
7 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about LifeStance Health Group and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.

Peers LifeStance Health Group discloses

The companies named in LFST's own disclosed peer group.

Terms on this page

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}